• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因位点处的大片段缺失以及寻找该基因损伤存在的预测标志物。

Large deletion at the gene locus and search for predictive markers of the presence of a genetic lesion.

作者信息

Muscarella Lucia Anna, Turchetti Daniela, Fontana Andrea, Baorda Filomena, Palumbo Orazio, la Torre Annamaria, de Martino Danilo, Franco Renato, Losito Nunzia Simona, Repaci Andrea, Pagotto Uberto, Cinque Luigia, Copetti Massimiliano, Chiofalo Maria Grazia, Pezzullo Luciano, Graziano Paolo, Scillitani Alfredo, Guarnieri Vito

机构信息

Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo 71013, Italy.

Medical Genetics, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna 40138, Italy.

出版信息

Oncotarget. 2018 Apr 17;9(29):20721-20733. doi: 10.18632/oncotarget.25067.

DOI:10.18632/oncotarget.25067
PMID:29755684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5945533/
Abstract

The Hyperparathyroidism with Jaw-Tumours syndrome is caused by mutations of the gene: it has been suggested that early onset of the disease and high Ca levels may predict the presence of a mutation. We searched for large deletions at the locus in patients with: HPT-JT (nr 2), atypical adenoma (nr 7) or sporadic parathyroid carcinoma (nr 11) with a specific MLPA and qRT-PCR assays applied on DNA extracted from whole blood. A Medline search in database for all the papers reporting a gene mutation, clinical/histological diagnosis, age at onset, Ca, PTH levels for familial/sporadic cases was conducted with the aim to possibly identify biochemical/clinical markers predictive, in first diagnosis, of the presence of a gene mutation. A novel genomic deletion of the first 10 exons of the gene was found in a 3-generation HPT-JT family, confirmed by SNP array analysis. A classification tree built on the published data, showed the highest probability of having a mutation in subjects with age at the onset < 41.5 years (44/47 subjects, 93.6%, had the mutation). Whereas the lowest probability was found in subjects with age at the onset ≥ 41.5 years and Ca levels <13.96 mg/dL (7/20 subjects, 35.0%, had the mutation, odds ratio = 27.1, < 0.001). We report a novel large genomic CDC73 gene deletion identified in an Italian HPT-JT family. Age at onset < 41.5 ys and Ca > 13.96 mg/dL are predictive for the presence of a CDC73 genetic lesion.

摘要

颌骨肿瘤综合征性甲状旁腺功能亢进由该基因的突变引起

有人提出,疾病的早发和高钙水平可能预示着该突变的存在。我们运用特定的多重连接依赖探针扩增(MLPA)和定量逆转录聚合酶链反应(qRT-PCR)检测方法,对从全血中提取的DNA进行检测,以寻找患有颌骨肿瘤综合征性甲状旁腺功能亢进(2例)、非典型腺瘤(7例)或散发性甲状旁腺癌(11例)患者的该基因座大片段缺失情况。在数据库中进行医学文献检索,查找所有报告该基因突变、临床/组织学诊断、发病年龄、钙和甲状旁腺激素水平的家族性/散发性病例的论文,目的是可能识别在初次诊断时预测该基因突变存在的生化/临床标志物。在一个三代颌骨肿瘤综合征性甲状旁腺功能亢进家族中发现了该基因前10个外显子的一个新的基因组缺失,经单核苷酸多态性(SNP)阵列分析证实。基于已发表数据构建的分类树显示,发病年龄<41.5岁的受试者发生该突变的概率最高(47例受试者中有44例,93.6%,发生了突变)。而发病年龄≥41.5岁且钙水平<13.96mg/dL的受试者发生该突变的概率最低(20例受试者中有7例,35.0%,发生了突变,优势比=27.1,P<0.001)。我们报告了在一个意大利颌骨肿瘤综合征性甲状旁腺功能亢进家族中鉴定出的一个新的该基因大片段基因组缺失。发病年龄<41.5岁和钙>13.96mg/dL可预测该基因病变的存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/17b33d6b5429/oncotarget-09-20721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/124d7a14d192/oncotarget-09-20721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/6e22ee91858f/oncotarget-09-20721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/08cdfd311cba/oncotarget-09-20721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/3b5c669b478a/oncotarget-09-20721-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/17b33d6b5429/oncotarget-09-20721-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/124d7a14d192/oncotarget-09-20721-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/6e22ee91858f/oncotarget-09-20721-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/08cdfd311cba/oncotarget-09-20721-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/3b5c669b478a/oncotarget-09-20721-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9aea/5945533/17b33d6b5429/oncotarget-09-20721-g005.jpg

相似文献

1
Large deletion at the gene locus and search for predictive markers of the presence of a genetic lesion.基因位点处的大片段缺失以及寻找该基因损伤存在的预测标志物。
Oncotarget. 2018 Apr 17;9(29):20721-20733. doi: 10.18632/oncotarget.25067.
2
Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.一个三代甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征家系中 CDC73(exon4-10)大片段基因内缺失。
BMC Med Genet. 2017 Aug 3;18(1):83. doi: 10.1186/s12881-017-0445-0.
3
A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.一个患有甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征的意大利家族中的一种新型CDC73基因突变。
Cell Oncol (Dordr). 2014 Aug;37(4):281-8. doi: 10.1007/s13402-014-0187-3. Epub 2014 Aug 12.
4
Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.中国人群中由CDC73基因种系大片段缺失或点突变引起的家族性孤立性原发性甲状旁腺功能亢进症/甲状旁腺功能亢进-颌骨肿瘤综合征
Clin Endocrinol (Oxf). 2014 Aug;81(2):222-30. doi: 10.1111/cen.12461. Epub 2014 May 6.
5
Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.检测到一个 HPT-JT 综合征家族中的首个 CDC73 种系大片段缺失。
Genes Chromosomes Cancer. 2011 Nov;50(11):922-9. doi: 10.1002/gcc.20911. Epub 2011 Aug 11.
6
HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.罗马尼亚首例诊断为甲状旁腺功能亢进-颌骨肿瘤综合征且携带CDC73基因种系突变的家族中甲状旁腺癌的高风险及基因筛查
Acta Endocrinol (Buchar). 2019 Jul-Sep;15(3):398-403. doi: 10.4183/aeb.2019.398.
7
Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.一名有甲状旁腺功能亢进-颌骨肿瘤综合征病史且已治愈的全身性骨纤维囊性骨炎患者的肿瘤抑制基因突变:病例报告及遗传病理生理学综述
J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Epub 2014 Sep 28.
8
Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.细胞分裂周期73基因缺失的小鼠会发生甲状旁腺和子宫肿瘤:一种甲状旁腺功能亢进-颌骨肿瘤综合征的模型。
Oncogene. 2017 Jul 13;36(28):4025-4036. doi: 10.1038/onc.2017.43. Epub 2017 Mar 13.
9
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.法国原发性甲状旁腺功能亢进症患者的一个全国性队列中频繁出现大型种系 HRPT2 缺失。
J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Epub 2013 Jan 4.
10
Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.与一种新型CDC73突变相关的早发型、严重且复发性原发性甲状旁腺功能亢进症。
Endocr J. 2015;62(7):627-32. doi: 10.1507/endocrj.EJ15-0057. Epub 2015 May 8.

引用本文的文献

1
Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of Gene and Parafibromin-Deficient Tumours.甲状旁腺功能亢进-颌骨肿瘤综合征的研究进展:从内分泌学角度到基因和副甲状腺素缺乏性肿瘤谱。
Int J Mol Sci. 2024 Feb 15;25(4):2301. doi: 10.3390/ijms25042301.
2
Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome.家族性嗜酸细胞性甲状旁腺肿瘤伴甲状旁腺功能亢进-颌骨肿瘤综合征中与恶性特征呈负相关的致病性线粒体 DNA 突变负荷。
Cells. 2021 Oct 28;10(11):2920. doi: 10.3390/cells10112920.
3

本文引用的文献

1
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.甲状旁腺癌的综合征型和非综合征型的分子遗传学。
Hum Mutat. 2017 Dec;38(12):1621-1648. doi: 10.1002/humu.23337. Epub 2017 Sep 25.
2
A nationwide study on parathyroid carcinoma.一项关于甲状旁腺癌的全国性研究。
Acta Oncol. 2017 Jul;56(7):991-1003. doi: 10.1080/0284186X.2017.1306103. Epub 2017 Mar 31.
3
Genomic profiling reveals mutational landscape in parathyroid carcinomas.基因组分析揭示甲状旁腺癌的突变特征。
Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors.
Yes 相关蛋白 1 是人类甲状旁腺肿瘤中新型的钙敏感受体靶点。
Int J Mol Sci. 2021 Feb 18;22(4):2016. doi: 10.3390/ijms22042016.
4
Rare Somatic MEN1 Gene Pathogenic Variant in a Patient Affected by Atypical Parathyroid Adenoma.非典型甲状旁腺腺瘤患者中罕见的体细胞MEN1基因致病性变异
Int J Endocrinol. 2020 Apr 27;2020:2080797. doi: 10.1155/2020/2080797. eCollection 2020.
5
Hyperparathyroidism Jaw Tumor Syndrome Presenting as Recurrent Femur Fractures in a Young Woman; a Rare Presentation of a Rare Disease.甲状旁腺功能亢进颌骨肿瘤综合征在一名年轻女性中表现为复发性股骨骨折;一种罕见疾病的罕见表现。
Case Rep Endocrinol. 2020 Mar 16;2020:9298147. doi: 10.1155/2020/9298147. eCollection 2020.
6
Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.我们对甲状旁腺功能亢进综合征认识的演变:历史视角。
J Bone Miner Res. 2019 Jan;34(1):22-37. doi: 10.1002/jbmr.3650. Epub 2018 Dec 10.
JCI Insight. 2017 Mar 23;2(6):e92061. doi: 10.1172/jci.insight.92061.
4
Association of parathyroid carcinoma and thyroid disorders: A clinical review.甲状旁腺癌与甲状腺疾病的关联:一项临床综述
Endocrine. 2017 Apr;56(1):19-26. doi: 10.1007/s12020-016-1147-7. Epub 2016 Oct 15.
5
Parathyroid Cancer in the Pediatric Patient.小儿甲状旁腺癌
J Pediatr Hematol Oncol. 2016 Jan;38(1):32-7. doi: 10.1097/MPH.0000000000000443.
6
Parathyroid carcinoma: Challenges in diagnosis and treatment.甲状旁腺癌:诊断与治疗中的挑战
Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21.
7
Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis.细胞质副纤维瘤蛋白/hCdc73 靶向并破坏 p53 mRNA 以控制 p53 介导的细胞凋亡。
Nat Commun. 2014 Nov 12;5:5433. doi: 10.1038/ncomms6433.
8
CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.家族性原发性甲状旁腺功能亢进症伴甲状旁腺癌中CDC73基因内缺失
J Clin Endocrinol Metab. 2014 Sep;99(9):3044-8. doi: 10.1210/jc.2014-1481. Epub 2014 May 13.
9
Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.中国人群中由CDC73基因种系大片段缺失或点突变引起的家族性孤立性原发性甲状旁腺功能亢进症/甲状旁腺功能亢进-颌骨肿瘤综合征
Clin Endocrinol (Oxf). 2014 Aug;81(2):222-30. doi: 10.1111/cen.12461. Epub 2014 May 6.
10
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.法国原发性甲状旁腺功能亢进症患者的一个全国性队列中频繁出现大型种系 HRPT2 缺失。
J Clin Endocrinol Metab. 2013 Feb;98(2):E403-8. doi: 10.1210/jc.2012-2789. Epub 2013 Jan 4.